Medical studies have linked Bristol-Myers Squibb and Otsuka Pharmaceutical Company’s top-selling antipsychotic drug, Abilify, to binge eating, pathological gambling and other compulsive behaviors, and individuals who experienced these unexpected urges while taking Abilify are now bringing legal claims against the drug makers. If you believe you have been adversely affected by compulsive gambling or another alleged side effect of Abilify, consult a knowledgeable product liability lawyer today for legal help. You may have grounds to file an Abilify lawsuit against Otsuka and Bristol-Myers Squibb, in order to seek fair and timely reimbursement for your gambling losses, psychological distress, and other related damages.
Abilify and other atypical antipsychotic drugs that work by altering the levels of serotonin and dopamine in the brain can have a harmful effect on the thoughts and actions of users, possibly resulting in unexpected compulsive behaviors, like pathological gambling, compulsive shopping, binge eating and even suicidal thoughts. Some possible alternative treatments for depression, schizophrenia and other mental health disorders may include:
October 2012 – The European Medicines Agency requires that Otsuka and Bristol-Myers warn patients and doctors in Europe about the potential for Abilify to cause pathological gambling side effects.
August 2013 – The Office of the Inspector General at the Department of Health and Human Services launches an investigation into the prescription of antipsychotic drugs like Abilify to children.
2014 – At least 29 reports of compulsive gambling problems from Abilify are submitted to the FDA’s Adverse Event Reporting System.
November 2015 – Drug regulators in Canada warn that there is “a link between use the of aripiprazole [Abilify] and a possible risk of pathological gambling or hypersexuality.”
May 2016 – The FDA issues a drug safety communication urging patients and doctors to watch out for symptoms of “uncontrollable urges to gamble, binge eat, shop, and have sex” following use of aripiprazole-containing drugs, like Abilify.
October 2008 – Research published in the Journal of Clinical Psychopharmacology outlines a case study involving a patient who developed symptoms of sex addiction after taking Abilify for schizophrenia.
March 2010 – A case study published in the Australian & New Zealand Journal of Psychology describes a woman with schizophrenia who took Abilify, ended up gambling away thousands of dollars, and gained nearly 20 pounds in six months due to binge eating side effects.
February 2011 – Researchers involved in an Abilify study published in Current Drug Safety recommend “consideration with increased attention on the appearance of pathological gambling symptoms among patients on aripiprazole.”
2011 – A case study finds evidence of pathological gambling side effects in Abilify users with schizophrenia who had no history of compulsive gambling habits prior to taking the drug.
July 2011 – Research conducted by the National Problem Gambling Clinic and published in the The British Journal of Psychiatry establishes a relationship between Abilify use and the drive to gamble in some patients.
September 2012 – The New York Times publishes an article calling for caution in regards to the prescription and use of antipsychotic medications like Abilify.
March 2014 – A French study outlining eight case reports involving pathological gambling side effects allegedly linked to Abilify treatment is published in the journal Addictive Behaviors.
December 2014 – JAMA Internal Medicine publishes a study finding a significant link between dopamine receptor agonists like Abilify and serious impulsive control disorders.
March 2016 – A study published in the medical journal JAMA Psychiatry concludes that children taking Abilify, Risperdal, Zyprexa and other popular antipsychotic drugs may face an increased risk of childhood diabetes.
Abilify is one of the top-grossing and best-selling drugs in the world, generating about $6.8 billion in sales for Otsuka and Bristol-Myers Squibb between April 2013 and March 2014. Product liability lawsuits brought against Otsuka Pharmaceutical Company and Bristol-Myers Squibb accuse the drug makers of:
The compulsive gambling individuals taking the antipsychotic Abilify may experience drives them to gamble by any means necessary, even if they can’t afford it, and sometimes results in them gambling with credit cards or borrowed money just to feed the urge. In severe instances, the individual may feel like he or she needs to gamble to continue living, and while this particular side effect may not cause physical injury, it can easily lead to psychological harm and ruin victims’ lives. Former Abilify users who are now facing crippling debt due to compulsive gambling from Abilify may be entitled to financial compensation to help cover the cost of their medical expenses, severe emotional injuries, loss of quality of life and gambling debts. Contact an experienced Abilify attorney today to discuss your legal options.